Healthcare stocks are higher, with the NYSE Healthcare Sector
Index rising 0.5% and shares of healthcare companies in the S&P
500 climbing 0.5% as a group.
In company news, UnitedHealth Group (
) is down more than 5.2% at $71.28 a share after the healthcare
insurer reported $30.62 billion in Q3 revenue, trailing the Capital
IQ consensus by around $270 million.
The company earned $1.53 per share, in line with estimates.
Looking forward, UNH expects FY13 EPS in a range of $5.40 to
$5.50, up from its prior forecast of $5.35 to $5.50 but still
trailing the Street view by at least $0.01.
The company also reaffirmed its outlook of around $122 billion
in revenue this year, also lagging the consensus call by $1.11
In other sector news,
(+) ORB, (+4.3%) Q3 EPS of $0.26 beats by $0.03 but revenue lags
consensus view. Reduces top end of FY13 revenue guidance but
remains in-line with Street view. Defers FY14 guidance due to
uncertainty over U.S. government spending.
(-) AMRN, (-61.2%) U.S. Food and Drug Administration advisory
committee declines to recommend its supplemental new drug
application for its fish-oil derived cholesterol drug Vascepa.
Copyright (C) 2013 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.